SLC3A2 Silencing Alleviates Aortic Dissection via cAMP‐PKA Activation and Disulfidptosis Inhibition
The FASEB Journal · 30.11.2026 · 40 (22)
DOI: 10.1096/fj.202604022r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 18.11.2026. Verfasst von Yaling Li und 7 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Aortic dissection (AD) is a life‐threatening cardiovascular emergency. Disulfidptosis, a novel disulfide stress‐induced cell death, remains unexplored in AD. We investigated whether solute carrier family 3 member 2 (SLC3A2), a disulfidptosis‐related gene, contributes to AD pathogenesis. Bioinformatic analyses of Gene Expression Omnibus datasets combined machine learning algorithms to identify SLC3A2 as a core gene. A murine AD model was established using β‐aminopropionitrile and angiotensin II, with lentiviral knockdown of SLC3A2. Human aortic vascular smooth muscle cells (HAVSMCs) were challenged with BAY‐876 to induce disulfidptosis. Histological staining evaluated medial degeneration and elastic fiber integrity. Disulfidptosis was assessed by measuring cystine accumulation and the protein expression of filamin A (FLNA) and NCK‐associated protein 1 (NCKAP1). The involvement of cyclic adenosine monophosphate (cAMP)‐protein kinase A (PKA) signaling was verified by genetic knockdown of its catalytic subunit (PRKACA). We observed SLC3A2 was upregulated in AD. SLC3A2 knockdown delayed lethal aortic rupture, reduced aortic medial degeneration, decreased reactive oxygen species and cystine, while restoring glutathione and free thiols. In HAVSMCs, SLC3A2 silencing preserved filamentous actin integrity, reversed the BAY‐876‐induced downregulation of α‐smooth muscle actin and smooth muscle 22 alpha, and restored the aberrant expression of FLNA and NCKAP1. Mechanistically, SLC3A2 knockdown reactivated the cAMP‐PKA signaling axis suppressed by BAY‐876, and PRKACA knockdown abrogated the protective effects of SLC3A2 silencing on oxidative stress, cytoskeletal integrity, and disulfidptosis. In conclusion, SLC3A2 drives AD progression by suppressing cAMP‐PKA signaling, thereby exacerbating oxidative stress and disulfidptotic cytoskeletal collapse. Targeting the SLC3A2/cAMP‐PKA axis represents a promising therapeutic strategy for AD.
Zitieren
APA
Li, Y., Xie, J., Song, Z., Mei, L., Yu, X., Lin, J., Wang, X., & Bi, S. (2026). SLC3A2 Silencing Alleviates Aortic Dissection via cAMP‐PKA Activation and Disulfidptosis Inhibition. The FASEB Journal, 40(22). https://doi.org/10.1096/fj.202604022r
Vancouver
Li Y, Xie J, Song Z, Mei L, Yu X, Lin J, et al. SLC3A2 Silencing Alleviates Aortic Dissection via cAMP‐PKA Activation and Disulfidptosis Inhibition. The FASEB Journal. 2026;40(22). doi:10.1096/fj.202604022r
BibTeX
@article{Li2026,
author = {Li, Yaling and Xie, Jiahong and Song, Zhigao and Mei, Lugang and Yu, Xuefei and Lin, Jinli and Wang, Xiaowu and Bi, Shenghui},
title = {SLC3A2 Silencing Alleviates Aortic Dissection via cAMP‐PKA Activation and Disulfidptosis Inhibition},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {22},
doi = {10.1096/fj.202604022r}
}
EUVIMED